ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Forge Receives Notice of Allowance from USPTO Covering Novel Chemistry Targeting LpxC
August 15, 2019Forge Therapeutics announced the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for its patent application directed to compositions of matter and methods of use of certain 'non-hydroxamate' inhibitors of LpxC for the tr
Pharma Sources Insight January 2025
